Airbus SE logo

AIR - Airbus SE News Story

€96.56 0.7  0.7%

Last Trade - 4:35pm

Large Cap
Market Cap £64.71bn
Enterprise Value £66.99bn
Revenue £42.72bn
Position in Universe 14th / 849

UPDATE 1-French artificial heart maker Carmat prepares for commercial launch in Q2

Wed 6th January, 2021 7:27am
(Adds detail and background)
    PARIS, Jan 6 (Reuters) - French artificial heart maker
Carmat  ALCAR.PA  said on Wednesday that it was preparing for
the commercial launch of its products in the second quarter of
this year, in a European market which could have at least 2,000
patients annually.
    Carmat said its artificial heart would be marketed under the
brand name of "Aeson". Aeson would be launched commercially in
Germany in the second quarter, while the French market would be
targeted around the same time.
    "I am happy to confirm that we will be ready to start
selling our product as early as Q2 2021," said Carmat Chief
Executive Stephane Piat.
    Last month, Carmat got European regulatory approval for its
product, sending its shares higher.*:nL1N2J40DU
    Airbus'  AIR.PA  subsidiary Matra Defense owns a 13% stake
in Carmat, while the ALIAD venture capital unit of Air Liquide
 AIRP.PA  has a 0.6% stake.

 (Reporting by Sudip Kar-Gupta; Editing by Jacqueline Wong,
editing by Louise Heavens)
 ((; +33 1 49 49 53 84;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.